Katsuhiko Hasumi
No ORCID on file
· 3 papers in corpus
· active 1989-1991
Nineteen patients (pts) with stage Ib to IIb uterine cervical cancer were studied for changes in bone mineral density and bone turnover within 12 months after radical hysterectomy and pelvic lymphadenectomy. Eleven out of 19 pts also underw…
子宮内膜症の治療薬であるDanazolを, 子宮内膜増殖症患者9例に1日400mg, 6ヵ月間経口投与し, その病理組織学的, 細胞診断学的変化を検討した.1) 嚢胞性腺増殖症7症例中全例がDanazolに反応し, 投与開始後1-12ヵ月で嚢胞性腺増殖症が消失した。7症例中4症例に投与終了後3-9ヵ月で嚢胞性腺増殖症の再発をみたが, Danazolの再投与によって嚢胞性腺増殖症は消失した.2) 腺腫性増殖症2症例中1症例は, 投与開始後4ヵ月で腺腫性増殖症が消失した. 他の1…
With an enzymatic technique, serum sialic acid (SA) levels were determined in patients with gynecologic tumors. Since the SA level for healthy females was 57.4 +/- 7.3 mg/dl, we set the upper normal limit of this parameter at 72 mg/dl. The …